<div id="readability-page-1" class="page"><div> <h2>Key Points</h2><ul><li>Berkshire ended 2025 with a huge cash pile.</li><li>The company continued to be a net seller of stocks in Q4 and didn't buy back any of its own shares. </li><li>10 stocks we like better than Berkshire Hathaway ›</li></ul>Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an &#34;Indispensable Monopoly&#34; providing the critical technology Nvidia and Intel both need. Continue »When Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) reported its Q4 results over the weekend, the conglomerate was once again flush with cash on its balance sheet. The market had a strong 2025 and is hanging in there thus far in 2026, so it makes you wonder if Berkshire is being too patient with its cash.The company ended the year with a whopping $373.3 billion in cash. That was down from the record $381.6 billion in cash the company had at the end of Q3, as it spent $9.7 billion to acquire OxyChem, the chemical subsidiary of holding Occidental Petroleum.<img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9lZGl0b3JpYWwvaW1hZ2VzLzg1ODk3Ny9icmsucG5nJnc9NzAw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="700" height="466" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9lZGl0b3JpYWwvaW1hZ2VzLzg1ODk3Ny9icmsucG5nJnc9NzAw"/>Image source: The Motley Fool. However, Berkshire was once again a net seller of stocks for the 13th straight quarter. Its main source of funds continues to be from the sales of Apple and Bank of America, two stocks it has been selling pretty consistently. Apple, however, remains Berkshire's largest holding, and new CEO Greg Abel pointed to it as being a long-term core holding, along with American Express, Coca-Cola, and Moody's in the U.S. He also highlighted several Japanese companies that fell into this bucket, as well. Berkshire once again decided not to repurchase any of its own shares. It was the sixth straight quarter that the company has decided not to do a buyback. However, the company did start to buy back shares earlier this month.In the past, Berkshire would repurchase its shares when they were trading at 1.1 times book value or below, before later increasing it to 1.2 times. More recently, it stopped using price-to-book ratio (P/B) altogether, with former CEO Warren Buffett saying the metric wasn't always reflective of the stock's intrinsic value. The stock has come down from the 1.8 P/B it had reached and is now around 1.4 times, which is a bit more in line with where the stock has traded over the past several years. In his first annual letter as CEO, Abel preached patience with Berkshire's huge cash hoard, saying the company needed to remain disciplined and wait for its pitch in the heart of the zone.He also emphasized the importance of risk management, including outside its large insurance businesses.<h2>Is it time to buy Berkshire stock?</h2>Investors seem to have started to become a bit frustrated with Berkshire's lack of action, and with Buffett no longer at the helm, they may not have the same patience with its new CEO. However, taking a large stake in a stock in which Berkshire doesn't have conviction or buying its own stock at an unattractive valuation also aren't smart moves. That said, in a world where technology is quickly coming to dominate, Berkshire's lack of expertise in this area is notable.I think Berkshire will be a good long-term investment and that the stock is finally starting to approach a more attractive valuation. Meanwhile, with the recent buyback, the company finally finds its own stock valuation attractive enough to buy its own shares, so investors can begin to follow suit.<h2>Should you buy stock in Berkshire Hathaway right now?</h2> Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Berkshire Hathaway wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $534,008!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,090,073!* Now, it’s worth noting Stock Advisor’s total average return is 949% — a market-crushing outperformance compared to 190% for the S&amp;P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of March 9, 2026. Bank of America is an advertising partner of Motley Fool Money. American Express is an advertising partner of Motley Fool Money. Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple, Berkshire Hathaway, and Moody's. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. </div></div>

BRK.A

BRK.B

Berkshire Hathaway ended 2025 with $373.3 billion in cash, down from $381.6 billion in Q3, after acquiring OxyChem. The company has been a net seller of stocks for 13 consecutive quarters, primarily selling Apple and Bank of America shares. New CEO Greg Abel emphasized patience with the cash hoard and risk management. Investors are growing frustrated with the lack of buybacks, as Berkshire has not repurchased shares for six quarters. Despite this, analysts suggest Berkshire may be approaching an attractive valuation for investment, although it was not included in a recent list of top stock recommendations.

- Berkshire Hathaway ended 2025 with $373.3 billion in cash, a reduction from the previous quarter after acquiring OxyChem.  
- The company was a net seller of stocks for the 13th consecutive quarter and chose not to repurchase shares for the sixth straight quarter, indicating a patient approach under new CEO Greg Abel.  
- While some investors express frustration over Berkshire's lack of action, analysts suggest considering other stocks identified by Stock Advisor for potentially higher returns.

Is Berkshire Hathaway Being Too Patient With Its Cash?